Thrift AP, et al. - Given that statin use is associated with a lower risk of developing hepatocellular carcinoma (HCC), researchers ascertained if postdiagnosis statin use was correlated with a reduced risk of death in patients with HCC. In the Veterans Administration Central Cancer Registry, they carried out a retrospective analysis of data from 15,422 patients with HCC, diagnosed between 2002 and 2016. According to findings, the use of statins (high or low doses) after a diagnosis of HCC was related to decreased mortality in a retrospective analysis of data from veterans with HCC.